These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 929148)

  • 1. [Cushing's syndrome and adrenal suppression by means of intranasal use of dexamethasone preparations].
    Reiner M; Galeazzi RL; Studer H
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1836-7. PubMed ID: 929148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.
    Kimmerle R; Rolla AR
    Am J Med; 1985 Oct; 79(4):535-7. PubMed ID: 4050838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cushing's syndrome and adrenal gland depression caused by intranasal spray containing dexamethasone in 2 siblings].
    Varotti C; Passarini B; Pasquali R
    G Ital Dermatol Venereol; 1987 Mar; 122(3):121-3. PubMed ID: 3596646
    [No Abstract]   [Full Text] [Related]  

  • 4. [Iatrogenic Cushing syndrome and mutatio tarda caused by dexamethasone containing nose drops].
    Fuchs M; Wetzig H; Kertscher F; Täschner R; Keller E
    HNO; 1999 Jul; 47(7):647-50. PubMed ID: 10463118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic Cushing's syndrome and adrenal insufficiency in infants on intranasal dexamethasone drops for nasal obstruction - Case series and literature review.
    Joshi RR; Maresh A
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():123-126. PubMed ID: 29447799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical glucocorticoid application causing iatrogenic Cushing's syndrome followed by secondary adrenal insufficiency in infants: two case reports.
    Matejek N; Hoos J; Holterhus PM; Bettendorf M; Choukair D
    J Med Case Rep; 2022 Dec; 16(1):455. PubMed ID: 36476353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic Cushing's Syndrome Due to Intranasal Usage of Ophthalmic Dexamethasone: A Case Report.
    Orton S; Censani M
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Self-induced Cushing's syndrome due to dexamethasone abuse in nasal spray: clinical and biochemical study].
    Sastre J; Díez JJ; López Guzmán A; Iglesias P; Martínez I; Gómez-Pan A
    An Med Interna; 1994 Apr; 11(4):181-4. PubMed ID: 8043738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
    Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ
    J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia.
    Lamberts SW; Bons EG; Bruining HA
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1106-10. PubMed ID: 6327752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of exogenous Cushing's syndrome due to unlicensed medications.
    Azizi F; Jahed A; Hedayati M; Lankarani M; Bejestani HS; Esfahanian F; Beyraghi N; Noroozi A; Kobarfard F
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):921-5. PubMed ID: 18462262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between adrenal cortex pathology in Cushing's syndrome and its response to the dexamethasone suppression test.
    Akçay G; Orhan Y; Aral F; Ozbey N; Azezli A; Molvalilar S; Sencer E
    J Int Med Res; 1996; 24(3):278-83. PubMed ID: 8725989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous Cushing's syndrome due to a Chinese herbalist's prescription of ointment containing dexamethasone.
    Franke V; Scholtens WF; von Rosenstiel IA; Walenkamp MJ
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28432185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic Cushing's syndrome following short-term intranasal steroid use.
    Dutta D; Shivaprasad KS; Ghosh S; Mukhopadhyay S; Chowdhury S
    J Clin Res Pediatr Endocrinol; 2012 Sep; 4(3):157-9. PubMed ID: 22985615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
    Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
    J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.